MiNK Therapeutics, Inc. SEC filings INKT
MiNK Therapeutics, Inc. has 265 filings in SEC EDGAR's recent list, going back to Jan 22, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 14, 2026 | Oct 11, 2026 |
| 144 | Notice of proposed sale | Oct 13, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Sep 23, 2025 |
| 3 | Initial insider ownership | Apr 9, 2026 | Mar 13, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Feb 27, 2026 |
| 4/A | Filing | Jan 14, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4/A | Filing | Oct 3, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 144 | Notice of proposed sale | Aug 29, 2025 | — |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Dec 9, 2024 | Oct 30, 2024 |
| 3 | Initial insider ownership | Dec 9, 2024 | Oct 30, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| SC 13G | Ownership over 5% (passive) | May 22, 2024 | — |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| SC 13D | Ownership over 5% (active) | Feb 14, 2024 | — |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Oct 16, 2023 | Oct 12, 2023 |
| 4 | Insider transaction | Oct 13, 2023 | Oct 11, 2023 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Aug 31, 2023 | Aug 29, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4/A | Filing | May 26, 2023 | May 5, 2023 |
| 4/A | Filing | May 26, 2023 | May 5, 2023 |
| 4/A | Filing | May 26, 2023 | May 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | May 26, 2023 | — |
| 4 | Insider transaction | May 12, 2023 | May 10, 2023 |
| 4 | Insider transaction | May 5, 2023 | May 5, 2023 |
| 4 | Insider transaction | May 5, 2023 | May 3, 2023 |
| 4 | Insider transaction | May 4, 2023 | May 2, 2023 |
| 4 | Insider transaction | May 3, 2023 | May 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | May 3, 2023 | — |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Jan 18, 2023 | Jan 16, 2023 |
| 4 | Insider transaction | Jan 12, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Jul 21, 2022 | Jul 18, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| 5 | Annual insider ownership | Feb 14, 2022 | Dec 31, 2021 |
| 4 | Insider transaction | Jan 25, 2022 | Jan 21, 2022 |
| 4 | Insider transaction | Jan 25, 2022 | Jan 21, 2022 |
| SC 13D | Ownership over 5% (active) | Oct 28, 2021 | — |
| 4 | Insider transaction | Oct 20, 2021 | Oct 19, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
| 3 | Initial insider ownership | Oct 20, 2021 | Oct 13, 2021 |
Showing 153 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1840229
- Former names
- AgenTus Therapeutics, Inc. (until Mar 18, 2021); AgenTus Therapeutics, Inc. (until Mar 18, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.